EuropaWire

Sandoz Advances Biosimilar Leadership with EU Introduction of Afqlir for Vision-Saving ...

Afqlir® is indicated to improve and maintain visual acuity in patients with nAMD, macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME) and myopic choroidal ...